We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 20 JULY 2018
Shire Defends Canadian Vyvanse® Patent Against Apotex's Impeachment Attacks

Gowling WLG
Contributor

Gowling WLG
The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...
View firm profileApotex's invalidity allegations regarding Shire's Canadian Patent 2,527,646 covering the active ingredient in Shire's ADHD medication VYVANSE®...
CanadaIntellectual Property




